InsidersTradesSigma
Track the 4DX share price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Market capitalisation: €2.4bn. The latest transaction was disclosed on 10 July 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. All data is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 4DX Hold (neutral), based on 3 analysts. Average price target: A$4.97.
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations5 total
ShareASXASX:2924-03110043-3A697003
0ShareASXASX:2924-03104476-3A696076
ShareASXASX:2924-03104103-3A696004
ShareASXASX:2924-03086279-3A692625
ShareASXASX:2924-03083235-3A692104
5 of 5 declarations
About 4DX
4DX is a company listed on the XASX, specializing in the development of innovative technologies in the healthcare sector. It focuses on enhancing medical treatments through data-driven solutions.